GERM
ETFMG Treatments, Testing and Advancements ETF
Save
About
The index tracks the performance of U. S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index.
Biggest holdings
Health care
6.82%
Health care
6.39%
Health care
6.22%
Health care
6.21%
Health care
5.98%
Health care
4.92%
Health care
4.06%
Health care
3.85%
Health care
3.82%
Health care
3.77%
Similar securities
Based on sector and market capitalization
Report issue